Gastric Cancer
Copyright ©The Author(s) 2005.
World J Gastroenterol. Aug 21, 2005; 11(31): 4776-4781
Published online Aug 21, 2005. doi: 10.3748/wjg.v11.i31.4776
Table 1 Clinicopathological characteristics of patients in three groups
Group A(n = 16)Group B(n = 16)Group C(n = 16)P
Sex (M/F)11/512/410/6NS
Age (yr)56.8±13.257.5±11.767.5±17.70.048
Sub-total/total gastrectomy11/510/610/6NS
Operation time (min)272±60312±69259±43NS
Blood loss (mL)216±106235±92196±137NS
Meperidine use (mg/d)83.3±21.691.4±31.279.3±15.9NS
Primary tumor1NS
pT3141314
pT4232
Stage2NS
II443
IIIa434
IIIb566
IV333
Table 2 Bowel motility recovery (mean days and standard deviation)
Group Aa (n = 16)Group Ba (n = 16)Group Ca (n = 16)P
First bowel flatus4.35±0.934.94±1.374.71±1.22NS
Time elapsed to glucose solution5.43±1.156.67±2.715.81±1.35NS
Time elapsed to soft diet7.21±1.9210.15±2.177.53±1.35<0.05
NG tube reinsertion (%)1 (6.25)9 (56.25)1 (6.25)<0.01
Table 3 Postoperative complications and mortality
Group Ab (n = 16)Group Bb (n = 16)Group Cb (n = 16)P
Death0110NS
Prolonged POI1 (6.25)9 (56.26)1 (6.25)<0.01
Wound infection212NS
Pneumonia232NS
Anastomotic leak001NS
Pancreatic leak332NS